EPL
EDBI Pte Ltd Portfolio holdings
AUM
$94.4M
This Quarter Return
-25.32%
1 Year Return
+32.71%
3 Year Return
+6.21%
5 Year Return
–
10 Year Return
–
AUM
$184M
AUM Growth
–
Cap. Flow
+$184M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
95.15%
Holding
19
New
19
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Joby Aviation
JOBY
|
$45.5M |
| 2 |
Grab
GRAB
|
$20.1M |
| 3 |
FMTX
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
|
$18M |
| 4 |
Sprinklr
CXM
|
$17.6M |
| 5 |
Snowflake
SNOW
|
$17.2M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 40.59% |
| 2 | Healthcare | 31.14% |
| 3 | Industrials | 28.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Joby Aviation
JOBY
$12.1B
| $45.5M | 24.72% |
+6,231,565
| New | +$45.5M |
|
|
2
Grab
GRAB
$20.3B
| $20.1M | 10.93% |
+2,822,035
| New | +$20.1M |
|
|
FMTX
3
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $18M | 9.8% |
+1,268,805
| New | +$18M |
|
|
4
Sprinklr
CXM
$2.24B
| $17.6M | 9.58% |
+1,110,777
| New | +$17.6M |
|
|
5
Snowflake
SNOW
$79.6B
| $17.2M | 9.32% |
+50,652
| New | +$17.2M |
|
|
WKME
6
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $15M | 8.13% |
+761,864
| New | +$15M |
|
7
Erasca
ERAS
$445M
| $13.8M | 7.52% |
+888,888
| New | +$13.8M |
|
8
Nuvation Bio
NUVB
$1.02B
| $10.8M | 5.87% |
+1,270,504
| New | +$10.8M |
|
|
IMAB
9
I-MAB
IMAB
$340M
| $10.5M | 5.72% |
+222,136
| New | +$10.5M |
|
10
Planet Labs
PL
$2.15B
| $6.55M | 3.56% |
+1,065,593
| New | +$6.55M |
|
11
AvePoint
AVPT
$3.47B
| $4.4M | 2.39% |
+700,000
| New | +$4.4M |
|
|
PEAR
12
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
| $2.64M | 1.44% |
+426,371
| New | +$2.64M |
|
13
Keros Therapeutics
KROS
$618M
| $591K | 0.32% |
+10,105
| New | +$591K |
|
14
Datadog
DDOG
$47.7B
| $437K | 0.24% |
+2,454
| New | +$437K |
|
15
Rapid Micro Biosystems
RPID
$107M
| $261K | 0.14% |
+24,515
| New | +$261K |
|
16
Relay Therapeutics
RLAY
$619M
| $230K | 0.13% |
+7,484
| New | +$230K |
|
17
Nurix Therapeutics
NRIX
$714M
| $215K | 0.12% |
+7,442
| New | +$215K |
|
18
ALX Oncology
ALXO
$62.7M
| $121K | 0.07% |
+5,613
| New | +$121K |
|
19
Olema Pharmaceuticals
OLMA
$375M
| $30K | 0.02% |
+3,181
| New | +$30K |
|